Cencora, Inc. vs Johnson & Johnson
COR vs JNJ — side-by-side comparison from reported financials. COR leads 6, JNJ leads 4 of 10 comparable metrics.
Cencora, Inc.
COR · Healthcare
$323.85+0.78%Solid
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | COR | JNJ |
|---|---|---|
| Price | $323.85 | $261.79 |
| Market cap | $61.8B | $631B |
| Revenue (TTM) | $333B | $97.9B |
| Revenue growth | +10.4% | +5.6% |
| Net margin | 0.8% | 21.5% |
| Free cash flow | $4.06B | $22.2B |
| Net cash (debt) | ($3.30B) | ($27.8B) |
| 1-year price return | +3.1% | +37.0% |
| P/E | 23.5 | 29.9 |
| P/E vs own history (cheap-side %) | 83% | 16% |
| Dividend yield | 0.76% | 2.00% |
| Return on equity | 106% | 26% |
| Altman Z-score | 3.66 | — |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 51,000 | 140,800 |
Full résumé-style profiles: COR CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.